|
Market Closed -
NYSE
07:00:02 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 994.58 USD | +1.40% |
|
-0.62% | +21.25% |
| 22/10 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 22/10 | McKesson Maintains Quarterly Dividend at $0.94 a Share, Payable Jan. 4, 2027 to Shareholders of Record as of Dec. 1 | MT |
Company Valuation: McKesson Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 45,858 | 48,757 | 70,547 | 84,343 | 105,996 | 115,958 | - | - |
| Change | - | 6.32% | 44.69% | 19.56% | 25.67% | 9.4% | - | - |
| Enterprise Value (EV) 1 | 48,205 | 49,673 | 71,593 | 84,306 | 108,547 | 119,557 | 119,146 | 117,862 |
| Change | - | 3.05% | 44.13% | 17.76% | 28.75% | 10.14% | -0.34% | -1.08% |
| P/E | 42.3x | 14.2x | 24x | 26.2x | 22.5x | 25.4x | 20.3x | 17.7x |
| PBR | -19.5x | -27.3x | -36.5x | -41.3x | -47.8x | -42.6x | -78.9x | -329x |
| PEG | - | 0x | -2.3x | 1.8x | 0.5x | 13.65x | 0.8x | 1.2x |
| Capitalization / Revenue | 0.17x | 0.18x | 0.23x | 0.23x | 0.26x | 0.27x | 0.25x | 0.23x |
| EV / Revenue | 0.18x | 0.18x | 0.23x | 0.23x | 0.27x | 0.28x | 0.26x | 0.24x |
| EV / EBITDA | 9.14x | 9.27x | 13.5x | 14x | 15.7x | 16x | 14.6x | 13.2x |
| EV / EBIT | 9.94x | 9.96x | 14.6x | 15x | 16.8x | 17.1x | 15.5x | 14.2x |
| EV / FCF | 12.4x | 10.8x | 19.7x | 16.1x | 20.1x | 25.4x | 19.7x | 18.1x |
| FCF Yield | 8.09% | 9.26% | 5.07% | 6.2% | 4.98% | 3.94% | 5.08% | 5.54% |
| Dividend per Share 2 | 1.83 | 2.09 | 2.4 | 2.75 | 3.17 | 3.577 | 3.64 | 4.009 |
| Rate of return | 0.6% | 0.59% | 0.45% | 0.41% | 0.37% | 0.36% | 0.37% | 0.4% |
| EPS 2 | 7.23 | 25.03 | 22.39 | 25.72 | 38.38 | 39.09 | 49.02 | 56.04 |
| Distribution rate | 25.3% | 8.35% | 10.7% | 10.7% | 8.26% | 9.15% | 7.43% | 7.15% |
| Net sales 1 | 263,966 | 276,711 | 308,951 | 359,051 | 403,430 | 431,854 | 461,421 | 493,463 |
| EBITDA 1 | 5,276 | 5,357 | 5,287 | 6,028 | 6,918 | 7,496 | 8,186 | 8,943 |
| EBIT 1 | 4,849 | 4,985 | 4,901 | 5,618 | 6,465 | 6,989 | 7,690 | 8,317 |
| Net income 1 | 1,114 | 3,560 | 3,002 | 3,295 | 4,762 | 4,868 | 5,704 | 6,263 |
| Net Debt 1 | 2,347 | 916 | 1,046 | -37 | 2,551 | 3,598 | 3,188 | 1,904 |
| Reference price 2 | 306.13 | 356.05 | 536.85 | 672.99 | 865.36 | 994.58 | 994.58 | 994.58 |
| Nbr of stocks (in thousands) | 149,798 | 136,939 | 131,408 | 125,326 | 122,487 | 116,590 | - | - |
| Announcement Date | 5/5/22 | 8/5/23 | 7/5/24 | 8/5/25 | 7/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.44x | 0.28x | 15.95x | 0.36% | 116B | |
| 41.42x | 14.04x | 31.11x | 0.48% | 1,263B | |
| 39.99x | 6.71x | 18.89x | 1.95% | 658B | |
| 36.71x | 8.6x | 17.71x | 2.33% | 521B | |
| 21.74x | 5.27x | 13.12x | 2.48% | 391B | |
| 106.24x | 6.06x | 25.8x | 2.28% | 369B | |
| 23.19x | 5.95x | 14.36x | 2.69% | 307B | |
| 24.47x | 4.89x | 13.59x | 1.77% | 290B | |
| 29.55x | 7.53x | 13.48x | 2.16% | 252B | |
| -41.18x | 7.46x | 46.76x | 1.93% | 212B | |
| Average | 30.76x | 6.68x | 21.08x | 1.84% | 437.79B | |
| Weighted average by Cap. | 36.85x | 8.60x | 22.63x | 1.66% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MCK Stock
- Valuation McKesson Corporation
Select your edition
All financial news and data tailored to specific country editions
